Package 13668-567-30

{"route": ["ORAL"], "spl_id": "8d94d098-d4f5-488c-8cc9-d21f32b727ec", "openfda": {"nui": ["N0000175599", "N0000020026"], "upc": ["0313668565300", "0313668566307", "0313668568301", "0313668567304"], "unii": ["742SXX0ICT"], "rxcui": ["402019", "403957", "484814", "757707"], "spl_set_id": ["3ea7612b-b004-43ef-accc-34c8ec5146b8"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (13668-567-05)", "package_ndc": "13668-567-05", "marketing_start_date": "20190326"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (13668-567-30)", "package_ndc": "13668-567-30", "marketing_start_date": "20190326"}], "brand_name": "TADALAFIL", "product_id": "13668-567_8d94d098-d4f5-488c-8cc9-d21f32b727ec", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "13668-567", "generic_name": "TADALAFIL", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TADALAFIL", "active_ingredients": [{"name": "TADALAFIL", "strength": "10 mg/1"}], "application_number": "ANDA211839", "marketing_category": "ANDA", "marketing_start_date": "20190326", "listing_expiration_date": "20271231"}